🔎 Trials Near Me

Domov › Srdcové zlyhanie › Arizona

Klinické štúdie Srdcové zlyhanie v štáte Arizona

31 štúdií pre Srdcové zlyhanie hľadá účastníkov v zariadeniach v štáte Arizona.

Mestá v štáte Arizona

Oficiálny text štúdie (anglicky)

ELEVATE-HFpEF Clinical Study

  • Banner - University Medical Center Phoenix, Phoenix
Prebieha nábor
Vek 40 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06678841

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

  • Research Site, Phoenix
  • Research Site, Phoenix
Prebieha náborFáza 3
Vek 18 až 130 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06307652

A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy

  • TMC Hlthcr Clin Res Office, Tucson
  • Pima Heart and Vascular, Tucson
Prebieha náborFáza 2
Vek 40 až 84 · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT06979362

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

  • Research Site, Gilbert
  • Research Site, Sun City
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07761117

BiVACOR® Total Artificial Heart Early Feasibility Study

  • Banner - University Medical Center Phoenix, Phoenix
Prebieha nábor
Vek 18 až 70 · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT06174103

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  • HonorHealth, Phoenix
  • Medical Advancement Centers of Arizona, Phoenix
  • Pima Heart and Vascular Clinical Research, Tucson
  • a 1 ďalších
Prebieha náborFáza 3
Vek 18 až 99 · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT07037459

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

  • Research Site, Gilbert
  • Research Site, Tempe
  • Research Site, Tucson
Prebieha náborFáza 3
Vek 40 a viac · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT06677060

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

  • Phoenix, AZ Investigative Site CON-10115, Phoenix
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 10. 9. 2026 · NCT06024746

The WiSE®-UP Study (The WiSE System Utilization & Performance Study)

  • CardioVascular Associates of Mesa (CVAM), Mesa
  • Honor Health, Scottsdale
Prebieha náborObservačná štúdia
Vek 22 a viac · Všetky pohlavia · Aktualizované 10. 9. 2026 · NCT07098858

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

  • Glendale, AZ Investigative Site 10096, Glendale
  • Phoenix, AZ Investigative Site 10115, Phoenix
  • Scottsdale, AZ Investigative Site 10003, Scottsdale
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 10. 9. 2026 · NCT06008197

Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure

  • Mayo Clinic Phoenix, Phoenix
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 9. 2026 · NCT07069738

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

  • University of Arizona Sarver Heart Center, Tucson
Prebieha náborFáza 2
Vek 40 až 85 · Všetky pohlavia · Aktualizované 27. 8. 2026 · NCT06793371

Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

  • Banner--University Medical Center Phoenix, Phoenix
  • Mayo Clinic - Arizona, Phoenix
Prebieha nábor
Vek 21 a viac · Všetky pohlavia · Aktualizované 25. 8. 2026 · NCT05677100

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

  • Chandler
Prebieha náborObservačná štúdia
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 20. 8. 2026 · NCT00271180

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

  • Tenax Investigational Site, Tucson
Prebieha náborFáza 3
Vek 18 až 85 · Všetky pohlavia · Aktualizované 19. 8. 2026 · NCT07288398

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  • Mercy Gilbert Medical Center, Gilbert
  • Sun City Clinical Research, Glendale
  • Honor Health, Phoenix
  • a 1 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 8. 2026 · NCT07567001

Alleviant ALLAY-HF Study

  • Pima Heart and Vascular, Tucson
Prebieha nábor
Vek 40 a viac · Všetky pohlavia · Aktualizované 14. 8. 2026 · NCT05685303

Assessment of CCM in HF With Higher Ejection Fraction

  • CardioVascular Associates of Mesa, Mesa
  • Chan Heart Rhythm Institute, Mesa
  • Southwest Cardiovascular Associates, Mesa
  • a 4 ďalších
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 6. 8. 2026 · NCT05064709

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists

  • Phoenix, AZ Investigative Site FIN-10115, Phoenix
  • FIN-10401, Yuma, AZ, Yuma
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 10. 7. 2026 · NCT06033950

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

  • St. Joseph's Hospital and Medical Center, Phoenix
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 6. 2026 · NCT05934487

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

  • Banner-University Medical Center Phoenix, Phoenix
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 10. 6. 2026 · NCT06526195

Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)

  • Peak Heart and Vascular, Avondale
  • Banner Medical Center, Mesa
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 5. 2026 · NCT06641362

CCM OPEN HF Registry

  • Cardiovascular Associates of Mesa, Mesa
  • University of Arizona and Banner University Medical Center Phoenix, Phoenix
  • HonorHealth Research Institute, Phoenix
  • a 1 ďalších
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 4. 2026 · NCT07112924

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

  • Dignity Health Research Institute at Mercy Gilbert and Chandler Regional Medical Centers, Gilbert
  • Banner Health - Phoenix, Phoenix
  • Tucson Medical Center Health, Tucson
  • a 1 ďalších
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 13. 4. 2026 · NCT03142152

Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment

  • Gilbert Cardiology, Gilbert
  • Arizona Heart Foundation, Phoenix
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 12. 2. 2026 · NCT07403669

His-Bundle Corrective Pacing in Heart Failure

  • University of Arizona, Phoenix
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 2. 2026 · NCT05265520

Left vs Left Randomized Clinical Trial

  • Mercy Gilbert & Chandler Regional Medical Centers, Gilbert AZ, Gilbert
  • University of Arizona College of Medicine- Phoenix, Tucson
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2025 · NCT05650658

Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator

  • HonorHealth, Scottsdale
Prebieha náborFáza 4
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 9. 2025 · NCT06964464

Care Coordination to Assess Improvement in Outcomes in Hospital Readmissions

  • Multiple Locations, Phoenix
Prebieha náborVítaní zdravých dobrovoľníkov
Vek 18 a viac · Všetky pohlavia · Aktualizované 20. 3. 2024 · NCT04905160

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.